-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Karuna Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q1 2023.
- Karuna Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Karuna Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $1.42M, a 23533% increase year-over-year.
- Karuna Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $670K, a 52.8% decline from 2022.
- Karuna Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.42M, a 23533% increase from 2021.
- Karuna Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $6K, a 86% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)